Showing 1 - 8 results of 8 for search 'Marco G. Paggi', query time: 0.04s Refine Results
  1. 1
    Obituary: Armando Felsani (1947–2022)

    Obituary: Armando Felsani (1947–2022) by Marco G. Paggi

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Molecular Biology in Glioblastoma Multiforme Treatment

    Molecular Biology in Glioblastoma Multiforme Treatment by Claudia Abbruzzese, Michele Persico, Silvia Matteoni, Marco G. Paggi

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis

    Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis by Paola Matarrese, Rosa Vona, Barbara Ascione, Marco G. Paggi, Anna Maria Mileo

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma

    Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma by Michele Persico, Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, Anna Maria Campana, Veronica Villani, Andrea Pace, Marco G. Paggi

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response

    Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response by Silvia Matteoni, Paola Matarrese, Barbara Ascione, Lucia Ricci-Vitiani, Roberto Pallini, Veronica Villani, Andrea Pace, Marco G. Paggi, Claudia Abbruzzese

    Published 2021-11-01
    Get full text
    Article
  6. 6
    Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial

    Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial by Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa, Claudia Abbruzzese, Ilaria Cestonaro, Martina Corrà, Marta Padovan, Giulia Cerretti, Mario Caccese, Antonio Silvani, Paola Gaviani, Diana Giannarelli, Gennaro Ciliberto, Marco G. Paggi

    Published 2023-12-01
    Get full text
    Article
  7. 7
    Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2

    Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2 by Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, Michele Signore, Barbara Ascione, Elisabetta Iessi, Aymone Gurtner, Andrea Sacconi, Lucia Ricci-Vitiani, Roberto Pallini, Andrea Pace, Veronica Villani, Andrea Polo, Susan Costantini, Alfredo Budillon, Gennaro Ciliberto, Marco G. Paggi

    Published 2023-12-01
    Get full text
    Article
  8. 8
    SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation

    SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation by Lucia D''Antona, Rosario Amato, Cristina Talarico, Francesco Ortuso, Miranda Menniti, Vincenzo Dattilo, Rodolfo Iuliano, Francesco Gigliotti, Anna Artese, Giosuè Costa, Silvia Schenone, Francesca Musumeci, Claudia Abbruzzese, Lorenzo Botta, Francesco Trapasso, Stefano Alcaro, Marco G. Paggi, Nicola Perrotti

    Published 2015-03-01
    Get full text
    Article

Search Tools: